UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - IMMUNITYBIO INC ownership

IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 130 filers reported holding IMMUNITYBIO INC in Q3 2022. The put-call ratio across all filers is 1.40 and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC ownership history of IMMUNITYBIO INC
ValueSharesWeighting
Q2 2024$9,971,866
+915.1%
1,577,827
+762.5%
0.00%
Q1 2024$982,334
+7.0%
182,9300.0%0.00%
Q4 2023$918,310
+197.0%
182,9300.0%0.00%
Q3 2023$309,152
-7.1%
182,9300.0%0.00%
Q2 2023$332,9320.0%182,9300.0%0.00%
Q1 2023$332,932
-55.4%
182,930
+24.3%
0.00%
Q4 2022$746,294
-99.9%
147,198
+8.7%
0.00%
Q3 2022$672,715,000
+17.4%
135,355
-12.1%
0.00%
Q2 2022$573,018,000
+1.3%
154,037
+52.7%
0.00%
Q1 2022$565,832,000
-7.7%
100,8610.0%0.00%
Q4 2021$613,236,000
+45.9%
100,861
+133.8%
0.00%
Q3 2021$420,174,000
+13.5%
43,139
+66.4%
0.00%
Q2 2021$370,166,000
-28.1%
25,922
+19.5%
0.00%
Q1 2021$515,158,00021,7000.00%
Other shareholders
IMMUNITYBIO INC shareholders Q3 2022
NameSharesValueWeighting ↓
HARBOURVEST PARTNERS LLC 335,709$2,121,6811.13%
Accurate Wealth Management, LLC 560,000$3,561,6000.85%
ALLEN HOLDING INC /NY 687,571$4,345,4490.54%
SHEETS SMITH WEALTH MANAGEMENT 665,995$4,209,0880.50%
Cormorant Asset Management, LP 1,250,000$7,900,0000.46%
Clearwater Capital Advisors, LLC 482,549$3,049,7100.32%
WEALTH EFFECTS LLC 87,500$553,0000.20%
MERIDIAN INVESTMENT COUNSEL INC. 96,433$609,4570.19%
Virtus ETF Advisers LLC 56,107$354,5960.17%
COLLECTIVE FAMILY OFFICE LLC 70,355$444,6440.13%
View complete list of IMMUNITYBIO INC shareholders